BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 18439914)

  • 21. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
    Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
    EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sumoylation is involved in beta-catenin-dependent activation of Tcf-4.
    Yamamoto H; Ihara M; Matsuura Y; Kikuchi A
    EMBO J; 2003 May; 22(9):2047-59. PubMed ID: 12727872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancers.
    Yochum GS; Sherrick CM; Macpartlin M; Goodman RH
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):145-50. PubMed ID: 19966299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt/beta-catenin signaling: turning the switch.
    Cadigan KM
    Dev Cell; 2008 Mar; 14(3):322-3. PubMed ID: 18331712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury.
    Hao YQ; Su ZZ; Lv XJ; Li P; Gao P; Wang C; Bai Y; Zhang J
    Oncol Rep; 2015 May; 33(5):2438-44. PubMed ID: 25738917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.
    Lin YY; Hsu YH; Huang HY; Shann YJ; Huang CY; Wei SC; Chen CL; Jou TS
    J Clin Invest; 2012 May; 122(5):1881-94. PubMed ID: 22466651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
    Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
    Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.
    Hoogeboom D; Essers MA; Polderman PE; Voets E; Smits LM; Burgering BM
    J Biol Chem; 2008 Apr; 283(14):9224-30. PubMed ID: 18250171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.
    Qiang YW; Hu B; Chen Y; Zhong Y; Shi B; Barlogie B; Shaughnessy JD
    Blood; 2009 Apr; 113(18):4319-30. PubMed ID: 19196662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells.
    Buongiorno P; Pethe VV; Charames GS; Esufali S; Bapat B
    Mol Cancer; 2008 Sep; 7():73. PubMed ID: 18826597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
    Jin T; George Fantus I; Sun J
    Cell Signal; 2008 Oct; 20(10):1697-704. PubMed ID: 18555664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Protein Interaction between β-Catenin and Dnmt1 Regulates Wnt Signaling and DNA Methylation in Colorectal Cancer Cells.
    Song J; Du Z; Ravasz M; Dong B; Wang Z; Ewing RM
    Mol Cancer Res; 2015 Jun; 13(6):969-81. PubMed ID: 25753001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping of the Wnt/β-catenin/TCF response elements in the human versican promoter.
    Rahmani M; Carthy JM; McManus BM
    Methods Mol Biol; 2012; 836():35-52. PubMed ID: 22252626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visualization and exploration of Tcf/Lef function using a highly responsive Wnt/β-catenin signaling-reporter transgenic zebrafish.
    Shimizu N; Kawakami K; Ishitani T
    Dev Biol; 2012 Oct; 370(1):71-85. PubMed ID: 22842099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.